학술논문
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)
Document Type
Article
Author
Source
In Annals of Oncology January 2014 25(1):81-89
Subject
Language
ISSN
0923-7534